Enzymatica AB (publ) is a Swedish AB based in Lund, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2007, the company has 13 employees and reported revenue of SEK 51.3m in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med en av Alajmovic, Sana Lembrér, Nils Holger Rikard Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva forskning, utveckling och försäljning av innovativa produkter baserade på enzymteknologi samt därmed förenlig verksamhet.
In its most recent annual report (2025), Enzymatica AB (publ) reported revenue of SEK 51.3m, an increase of 19% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 52.5m, and the EBITDA margin stood at -103.4%.
At the end of 2025, current assets covered short-term debt 4.7 times.
Frequently asked questions
What is the Org number of Enzymatica AB (publ)?
Enzymatica AB (publ) is registered with Bolagsverket / SCB under Org 5567199244.
What is the revenue of Enzymatica AB (publ)?
Enzymatica AB (publ) reported revenue of SEK 51.3m in 2025.
How many employees does Enzymatica AB (publ) have?
Enzymatica AB (publ) employs 13 people as of the latest annual report.
Who is the CEO of Enzymatica AB (publ)?
Sana Alajmovic is the CEO of Enzymatica AB (publ), in role since 2026.
Who is the chairman of Enzymatica AB (publ)?
Bengt Baron chairs the board of Enzymatica AB (publ), in role since 2020.
Where is Enzymatica AB (publ) headquartered?
Enzymatica AB (publ)'s registered address is Scheelevägen 19.
